Simon Gibbs

4.9k total citations
76 papers, 2.2k citations indexed

About

Simon Gibbs is a scholar working on Molecular Biology, Hematology and Nephrology. According to data from OpenAlex, Simon Gibbs has authored 76 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 21 papers in Hematology and 19 papers in Nephrology. Recurrent topics in Simon Gibbs's work include Amyloidosis: Diagnosis, Treatment, Outcomes (47 papers), Parathyroid Disorders and Treatments (16 papers) and Multiple Myeloma Research and Treatments (15 papers). Simon Gibbs is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (47 papers), Parathyroid Disorders and Treatments (16 papers) and Multiple Myeloma Research and Treatments (15 papers). Simon Gibbs collaborates with scholars based in United Kingdom, Australia and United States. Simon Gibbs's co-authors include Ashutosh Wechalekar, Philip N. Hawkins, Jennifer H. Pinney, Helen J. Lachmann, Julian D. Gillmore, Carol Whelan, Dorota Rowczenio, Christopher P. Venner, Janet A. Gilbertson and Prayman Sattianayagam and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Simon Gibbs

71 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon Gibbs United Kingdom	18	1.8k	689	499	383	372	76	2.2k
Dorota Rowczenio United Kingdom	33	3.3k 1.9×	1.3k 1.9×	687 1.4×	538 1.4×	382 1.0×	86	3.8k
MA Gertz United States	19	1.4k 0.8×	322 0.5×	450 0.9×	101 0.3×	301 0.8×	32	1.7k
Bruno Royer France	27	1.3k 0.8×	249 0.4×	623 1.2×	52 0.1×	213 0.6×	84	2.5k
Candida Cristina Quarta Italy	29	3.8k 2.1×	1.9k 2.8×	1.0k 2.1×	1.3k 3.3×	334 0.9×	61	4.4k
Niall Swan Ireland	18	702 0.4×	143 0.2×	453 0.9×	23 0.1×	283 0.8×	59	1.4k
Eva Honsová Czechia	19	230 0.1×	449 0.7×	177 0.4×	76 0.2×	170 0.5×	73	1.3k
Sophia Jacob United States	7	509 0.3×	90 0.1×	66 0.1×	171 0.4×	146 0.4×	9	1.2k
Désirée Tampe Germany	17	612 0.3×	451 0.7×	283 0.6×	55 0.1×	63 0.2×	46	1.4k
Manfred Weber Germany	19	434 0.2×	317 0.5×	106 0.2×	99 0.3×	48 0.1×	40	1.2k
Barbara Hertel Germany	12	504 0.3×	86 0.1×	194 0.4×	155 0.4×	62 0.2×	14	1.0k

Countries citing papers authored by Simon Gibbs

Since Specialization

Citations

This map shows the geographic impact of Simon Gibbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Gibbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Gibbs more than expected).

Fields of papers citing papers by Simon Gibbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Gibbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Gibbs. The network helps show where Simon Gibbs may publish in the future.

Co-authorship network of co-authors of Simon Gibbs

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Gibbs. A scholar is included among the top collaborators of Simon Gibbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Gibbs. Simon Gibbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Judge, Daniel P., Kevin Alexander, Francesco Cappelli, et al.. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. 85(10). 1003–1014. 7 indexed citations

Luzio, Stephen D., Gareth Dunseath, WY Cheung, et al.. (2025). Does the short-term use of continuous glucose monitoring enhance diabetes self-management behaviour in type 2 diabetes? The DISCO GM Study: A randomised, controlled cross-over study. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 19(7). 103283–103283.

Gibbs, Simon, Gregory T. Jones, Nikki Earle, et al.. (2024). DNA methylation in the TXNIP gene is associated with type 2 diabetes in Pacific Peoples living in NZ. European Heart Journal. 45(Supplement_1). 2 indexed citations

Gibbons, A.J., N. Anderson, Fiona Kwok, et al.. (2023). Identifying Early Suboptimal Hematological Response in Patients with AL Amyloidosis Treated with Bortezomib-Based Chemotherapy. Blood. 142(Supplement 1). 2030–2030. 1 indexed citations

Wellard, Cameron, Dipti Talaulikar, Michael Löw, et al.. (2023). The prognostic impact of t(11;14) in multiple myeloma: A real‐world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR). SHILAP Revista de lepidopterología. 4(3). 639–646. 4 indexed citations

Kalff, Anna, Peter Mollee, P. Joy Ho, et al.. (2023). The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia. Internal Medicine Journal. 53(5). 819–824. 6 indexed citations

Wechalekar, Ashutosh, María Teresa Cibeira, Simon Gibbs, et al.. (2022). Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group. Amyloid. 30(1). 3–17. 46 indexed citations

Mollee, Peter, John Reynolds, Wojciech Janowski, et al.. (2021). A Randomized Study of Bortezomib, Cyclophosphamide and Dexamethasone Induction (VCD) Versus VCD and Daratumumab Induction Followed By Daratumumab Maintenance (VCDD) for the Initial Treatment of Transplant-Ineligible Patients with Multiple Myeloma (AMaRC 03-16). Blood. 138(Supplement 1). 2728–2728. 2 indexed citations

Lasica, Masa, et al.. (2020). 178 “The Giant Awakes” – Rapid Increases in the Diagnosis of Transthyretin (TTR) Amyloidosis After the ATTR-ACT Trial of Tafamidis. Heart Lung and Circulation. 29. S115–S115. 1 indexed citations

10.

Chua, Chong Chyn, Hui Yin Lim, Khai Li Chai, et al.. (2018). Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma. Bone Marrow Transplantation. 53(9). 1116–1123. 11 indexed citations

11.

Dungu, Jason, Oswaldo Valencia, Jennifer H. Pinney, et al.. (2014). CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis. JACC. Cardiovascular imaging. 7(2). 133–142. 235 indexed citations

12.

Seeger, Werner, Yochai Adir, Joan Albert Barberà, et al.. (2014). [Pulmonary hypertension in chronic lung diseases].. PubMed. 42 Suppl 1. 142–52. 4 indexed citations

13.

Venner, Christopher P., Julian D. Gillmore, Sajitha Sachchithanantham, et al.. (2014). A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis. Leukemia. 28(12). 2304–2310. 64 indexed citations

14.

Venner, Christopher P., Thirusha Lane, Darren Foard, et al.. (2012). Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival. Blood. 119(19). 4387–4390. 197 indexed citations

15.

Pinney, Jennifer H., Helen J. Lachmann, Prayman Sattianayagam, et al.. (2012). Renal Transplantation in Systemic Amyloidosis—Importance of Amyloid Fibril Type and Precursor Protein Abundance. American Journal of Transplantation. 13(2). 433–441. 60 indexed citations

16.

Sattianayagam, Prayman, Simon Gibbs, Dorota Rowczenio, et al.. (2011). Hereditary lysozyme amyloidosis – phenotypic heterogeneity and the role of solid organ transplantation. Journal of Internal Medicine. 272(1). 36–44. 60 indexed citations

17.

Rowczenio, Dorota, Ahmet Doǧan, Jason D. Theis, et al.. (2011). Amyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-I. American Journal Of Pathology. 179(4). 1978–1987. 90 indexed citations

18.

Gibbs, Simon & Philip N. Hawkins. (2010). Biochemical basis of the amyloid diseases. British Journal of Hospital Medicine. 71(2). 70–75. 1 indexed citations

19.

O’Brien, Pat, et al.. (2005). Smart card product development in an internet-based CRM environment. 56. 1 indexed citations

20.

Bozcuk, Hakan, R.T.D. Oliver, J.M. Barua, et al.. (2001). Phase 1/2 Study of Synchronous Methotrexate, Cisplatin, Vincristine (MOPq10) Chemotherapy and Radiation for Patients with Locally Advanced Bladder Cancer. Urologia Internationalis. 67(4). 293–297. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact